In PTSD experimental models, corticosterone levels, as well as nociceptin and NOP expression are increased in different brain regions and the cerebrospinal fluid, and consequently, NOP antagonists protect against molecular and behavioral deficits [162, 163]. This evidence concerns the gene PNOC and post-traumatic stress disorder.